News Outlets Examine Global Efforts To Develop Coronavirus Treatments, Vaccines

Financial Times: The global hunt for a coronavirus drug | Free to read (Kuchler et al., 3/26).

Financial Times: Gilead asks to rescind special status for potential coronavirus drug (Mancini et al., 3/25).

Nature: How blood from coronavirus survivors might save lives (Maxmen, 3/24).

NBC: Tracking the development of coronavirus treatments (Siegel, 3/25).

STAT: Under intense criticism, Gilead forsakes monopoly status for its experimental Covid-19 drug (Silverman, 3/25).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.